Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KOALA: BAY 2586116 in Obstructive Sleep Apnea
NCT04236440Phase 2Completed
- Sponsor
- Bayer
- Start
- Feb 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BAY2586116 in obstructive sleep apnea (OSA), sponsored by Bayer. Started Feb 2020; status: completed.
02
Drugs
BAY2586116
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT04236440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04236440.